Ribosome biogenesis in disease: new players and therapeutic targets.

Jiao L, Liu Y, Yu XY, Pan X, Zhang Y, Tu J, Song YH, Li Y

Open source

DOI
10.1038/s41392-022-01285-4
Published
2023 Jan 9
Container
Signal transduction and targeted therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41392-022-01285-4,
  title = {Ribosome biogenesis in disease: new players and therapeutic targets.},
  author = {Jiao L and Liu Y and Yu XY and Pan X and Zhang Y and Tu J and Song YH and Li Y},
  year = {2023},
  journal = {Signal transduction and targeted therapy},
  doi = {10.1038/s41392-022-01285-4},
  url = {https://doi.org/10.1038/s41392-022-01285-4}
}

RIS

TY  - JOUR
TI  - Ribosome biogenesis in disease: new players and therapeutic targets.
AU  - Jiao L
AU  - Liu Y
AU  - Yu XY
AU  - Pan X
AU  - Zhang Y
AU  - Tu J
AU  - Song YH
AU  - Li Y
PY  - 2023
JO  - Signal transduction and targeted therapy
DO  - 10.1038/s41392-022-01285-4
UR  - https://doi.org/10.1038/s41392-022-01285-4
ER  - 

APA

L, J., Y, L., XY, Y., X, P., Y, Z., J, T., YH, S., & Y, L. (2023). Ribosome biogenesis in disease: new players and therapeutic targets.. Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-022-01285-4

Source records